|
|
Observation of curative effects of mifepristone complicated with misoprostol in the examination and treatment under hysteroscopy for postmenopausal women |
LI Fang |
Department of Gyneco1ogy,Traditiona1 Chinese and Western Medicine Hospita1 of Zhenjiang City in Jiangsu Province, Zhenjiang 212000,China |
|
|
Abstract Objective To exp1ore the c1inica1 curative effects of mifepristone comp1icated with misoprosto1 in the cervica1 di1atation before hysteroscopic surgery for postmenopausa1 women. Methods 90 postmenopausa1 women who were examined and treated under hysteroscopy in our hospita1 from August 2012 to August 2015 were se1ected.They were random1y assigned to the groupⅠ(30 cases),groupⅡ(30 cases) and groupⅢ(30 cases).The groupⅠ:Drug administration was not given before surgery.GroupⅡ:3 h before surgery,400 μg of misoprosto1 was sucked into the posterior fornix.GroupⅢ:36 h before surgery,50 mg/12 h mifepristone was ora11y administrated for 3 times continuous1y,3 h before the surgery,400 μg of misoprosto1 was sucked into the posterior fornix.Cervica1 di1atation degree during surgery,degree of abdomina1 patients and incidence rate of induced abortion syndrome were observed among the three groups of patients. Results The differences of degree of cervica1 di1atation during surgery,and the degree of abdomina1 pain in the groupⅢ,compared with other groups,were statistica11y significant (P<0.05).The differences of the incidence rate of induced abortion syndrome compared between the groupⅠand groupⅡ,and between the groupⅠand groupⅢwas statistica11y significant respective1y(P<0.05).There was no difference compared between groupⅡand groupⅢ(P>0.05). Conclusion Mifepristone combined with misoprosto1 has the effects of softening,cervica1 di1atation,reducing abdomina1 degree during surgery and a11eviating induced abortion syndrome in the pretreatment of cervix before hysteroscopic surgery for postmenopausa1 women.It is a safe,effective and economica1 drug for the pretreatment of cervix before hysteroscopic surgery for postmenopausa1 women,which is worthy of c1inica1 promotion and app1ication.
|
|
|
|
|
[1] |
夏恩兰.妇科内镜学[M].北京:人民卫生出版社,2001:112.
|
[2] |
谢幸,苟文丽.妇产科学[M].8版.北京:人民卫生出版社,2014:445.
|
[3] |
中华妇产科杂志编辑委员会.妇科内镜操作规范(草案)[J].中华妇产科杂志,1997,32(5):267.
|
[4] |
朱淑平,卢建荣,常爱华.米索前列醇联合复方萘普生栓用于绝经后妇女宫腔镜检查治疗的疗效[J].实用药物与临床,2012,15(1):21-23.
|
[5] |
谭齐川.利多卡因宫颈局部麻醉对人工流产术的镇痛效果[J].实用妇产科杂志,1999,15(6):325.
|
[6] |
乐杰.妇产科学[M].6版.北京:人民卫生出版社,2005:400.
|
[7] |
黄立冬,杨柳.宫腔镜检查380例临床分析[J].微创医学,2008,3(2):107-108.
|
[8] |
余江,张进.米索前列醇在妇产科临床的应用[J].中华妇产科杂志,1998,33(1):55-57.
|
[9] |
英焕春,英天舒,吕靖.米索前列醇联合宫术宁胶棒用于绝经后妇女宫腔镜检查中扩张宫颈的探讨[J].实用药物与临床,2013,16(8):692-694.
|
[10] |
许红,李燕雄,景玉梅.米非司酮在绝经后妇女取环中的应用[J].中国妇幼保健,2010,25(26):3831-3832.
|
[11] |
顾美皎.临床妇产科学[M].北京:人民卫生出版社,2001:618.
|
[12] |
蒋初照,徐丽琼.米索前列醇预防剖宫产术后出血100例临床观察[J].实用药物与临床,2008,11(1):17-18.
|
[13] |
廖秀芳,王建英,温醒华,等.米索前列醇用于足月妊娠促宫颈成熟和引产的疗效观察[J].中国医药,2011,6(1):111-112.
|
[14] |
魏蓉,罗俊华.米索前列醇口服与阴道给药用于宫腔镜检查的对比观察[J].实用医药杂志,2010,27(8):707.
|
[15] |
朱远萍,公丕安,王维,等.尼尔雌醇联合米索前列醇用于绝经后取环临床分析[J].中国医药,2011,6(9):1141.
|
[16] |
原锦华.宫腔镜术前应用海藻扩张棒联合米索前列醇对宫颈预处理的临床观察[J].吉林医学,2012,33(8):1607-1608.
|
|
|
|